This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Altria Stock Trading at a Discount to Industry: Buy or Hold?
by Swati Prasad
MO trades at a steep discount with steady gains, but its momentum rests on pricing power, brand strength and managing persistent volume declines.
MO Expands Smokeable Margins to 64% as Cigarette Volumes Fall 9%
by Zacks Equity Research
Altria widens smokeable margins despite falling cigarette volumes, powered by pricing strength and premium-brand resilience.
Campbell's Readies for Q1 Earnings: Things to Watch for CPB Stock
by Zacks Equity Research
CPB faces tariff pressures and higher marketing costs, while steady at-home cooking may boost its Meals & Beverages results.
The Zacks Analyst Blog Highlights Palantir Technologies, Philip Morris International, TotalEnergies, Natural Resource Partners and Genie Energy
by Zacks Equity Research
Palantir, Philip Morris, TotalEnergies, NRP and GNE headline fresh Zacks research as analysts spotlight performance drivers, risks and outlook shifts.
Can Altria Sustain EPS Gains as Revenues Decrease 1.7% Y/Y?
by Zacks Equity Research
MO posts higher EPS despite falling revenues, leaning on margin gains and buybacks to offset declining volumes.
Top Analyst Reports for Palantir, Philip Morris & TotalEnergies
by Mark Vickery
Palantir surges as its AI platforms and defense projects lift momentum, while analyst reports track shifts across tobacco, energy and microcaps.
MO vs. PM: Which Tobacco Giant Is Winning the Smoke-Free Race?
by Swati Prasad
Altria and Philip Morris advance their smoke-free strategies as each leverages pricing, innovation and cost discipline in a shifting tobacco market.
Altria Narrows 2025 EPS Outlook: Is Margin Growth Peaking?
by Swati Prasad
MO narrows its 2025 EPS outlook as evolving margin trends across key segments point to more measured growth ahead.
Top Sin Stocks to Buy Now for Power, Predictability & Long-Term Gains
by Rajani Lohia
Sin stocks stand out as resilient plays, blending stable demand, pricing power and strategic shifts that support long-term growth potential.
Nicotine Pouches Hit 55.7% of Oral Tobacco: Where Does Altria Stand?
by Zacks Equity Research
Nicotine pouches dominate 55.7% of the oral market, raising pressure on MO as on! loses share and on! PLUS rolls out to boost its position.